Troluce Capital Advisors »

Stoke Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 653k 32.56

More positions owned by Troluce Capital Advisors

State Str Spdr S&p 500 Etf T Put Put Option
Applied Matls Put Put Option
Atlanta Braves Hldgs Com Ser C (BATRK)
Echostar Corp Cl A (SATS)
Echostar Corp Put Put Option
Invesco Exchange Traded Fd T Call Call Option
Capital One Financial (COF)
Capital One Finl Corp Put Put Option
Liberty Media Corp Del Com Lbty One S C (FWONK)
Live Nation Entertainment (LYV)
Aptiv Call Call Option
Ftai Aviation SHS (FTAI)
Terawulf (WULF)
Aptiv Com Shs (APTV)
Dycom Industries (DY)

View all positions for Troluce Capital Advisors

Top funds holding Stoke Therapeutics

FMR
Rtw Investments
BlackRock
Lynx1 Capital Management
Redmile Group
Morgan Stanley
Baker Bros. Advisors
Toronto-Dominion Bank
Vanguard Group
BVF
State Street Corporation
Vanguard Capital Management
Siren
Deerfield Management Company
Henderson Group

View all funds holding Stoke Therapeutics